RELMADA THERAPEUTICS, INC. (RLMD) Weighted Average Number of Shares Outstanding, Diluted 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Relmada Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2013 to 2024.
  • Relmada Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 30.1 M shares, a 0.11% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 30.1 M shares, a 1.59% increase from 2022.
  • Relmada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 29.6 M shares, a 68.8% increase from 2021.
  • Relmada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 17.6 M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 30.1 M +33 K +0.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 30.1 M +471 K +1.59% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 30.1 M +35.5 K +0.12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 30.1 M +163 K +0.55% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 30.1 M +1.71 M +6.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 29.6 M +12.1 M +68.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 30.1 M +12.6 M +72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 29.9 M +12.9 M +75.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 28.4 M +11.8 M +71.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 17.6 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 17.5 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 17.1 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 16.6 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2017 12 M +32.1 K +0.27% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12 M +616 K +5.39% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-10
Q3 2016 12 M -902 K -6.97% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q1 2016 12 M +1.26 M +11.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 11.4 M -2.67 M -18.9% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 12.9 M +4.79 M +58.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q1 2015 10.7 M -199 M -94.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 14.1 M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 8.15 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 210 M +186 M +772% Jan 1, 2014 Mar 31, 2014 8-K 2014-05-27
Q1 2013 24 M Jan 1, 2013 Mar 31, 2013 8-K 2014-05-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.